John D. Schneible Ph.D.

Patent Agent

1775 Pennsylvania Avenue, NW
Suite 1000
Washington, District of Columbia 20006


John is a patent agent supporting AGG’s Intellectual Property and Litigation practices, as well as the Dietary Supplements industry team.

John focuses primarily on prosecuting intellectual by assisting companies ranging in size from start-ups to Fortune 500 companies. John works with companies across variety of sectors, including genetic technologies, biological therapeutic and diagnostic molecules, pharmaceuticals, dietary supplements, and other consumer products.

Prior to joining AGG, John served as a patent examiner with the USPTO, examining applications related to steel articles, copper-based foils, and metal/glass coatings. John has a Ph.D. in chemical engineering and has authored over 10 peer-reviewed publications on drug delivery platforms and biologic purification technologies.


  • North Carolina State University, Doctor of Philosophy - Chemical Engineering
    • GAANN Teaching Fellow
    • Provost’s Doctoral Fellow
  • State University of New York at Buffalo, Bachelor of Science - Chemical Engineering,
    summa cum laude
    • Tau Beta Pi
  • United States Patent and Trademark Office
    • American Chemical Society
    • Alpha Phi Omega


  • “Chitosan: A Versatile Bio-platform for Breast Cancer Theranostics,” Journal of Control Release, December 2021
  • “Engineering Next Generation Cyclized Peptide Ligands for Light-controlled Capture and Release of Therapeutic Proteins,” Advance Functional Materials, May 2021
  • “Synthetic Platelet Microgels Containing Fibrin Knob B Mimetic Motifs Enhance Clotting Responses,” Advanced Therapeutics, March 2021
  • “Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands,” International Journal of Molecular Sciences, February 2021
  • “Natural and Synthetic Biopolymers in Drug Delivery and Tissue Engineering,” Chapter 9 in Biopolymers for Biomedical and Biotechnological Applications, November 2020
  • “A Multiscale Coarse-Grained Model to Predict the Molecular Architecture and Drug Transport Properties of Modified Chitosan Hydrogels,” Soft Matter, October 2020
  • “Peptides and Pseudopeptide Ligands: A Powerful Toolbox for the Affinity Purification of Current and Next-Generation Biotherapeutics,” Journal of Chromatography A, October 2020
  • “Chitosan Hydrogels for Synergistic Delivery of Chemotherapeutics to Triple Negative Breast Cancer Cells and Spheroids,” Pharmaceutical Research, July 2020
  • “Photoinduced Reconfiguration to Control the Protein-Binding Affinity of Azobenzene-Cyclized Peptides,” Journal of Materials Chemistry B, June 2020
  • “Modified Graphene Oxide (GO) Particles in Peptide Hydrogels: a Hybrid System Enabling Scheduled Delivery of Synergistic Combinations of Chemotherapeutics,” Journal of Materials Chemistry B, March 2020
  • “Tailoring the Chemical Modification of Chitosan Hydrogels to Fine-Tune the Release of a Synergistic Combination of Chemotherapeutics,” ACS Biomacromolecules, July 2019